Diabetic patients of black type and ethnic minority 2 may be disadvantaged in receiving the most recent treatment, according to studies.
Surrey University researchers analyzed data from the Royal College of General Practitioners Research and Surveillance network which covers 49,380 patients registered over 164 GP surgeries in England over 5 years to the end of 2016. Results are reported in PLOS Medicine .
Diabetes and Ethnicity
It is understood that Type 2 diabetes risks are higher in some ethnic groups, including black and South Asian patients.
The study found that black patients were:
HbA1c is less likely to be well managed by white patients and to have retinopathy testing t
50% less likely to prescribe SGLT2 inhibitors, GLP-1 agonists, and other newer medicines for white patients t
Glucose (CGM) is less likely to be monitored continuously for glycemic control
Patients from Asian background are:
The study was observational, using data collected retrospectively, and did not rule out any regional disparities in diabetes care.
Concerns related to difficulties
The study concludes that "difference in glycemic control, monitoring of diabetes and prescription of new therapies remains a challenge in diabetic care".
In news release, the chief author, Dr Martin Whyte, senior clinical lecturer in metabolic medicine at the University of Surrey, said: "The NHS succeeded in improving the quality of diabetes health care; but there is still an imbalance in care." Diagnosis rates for the type Diabetes is increasing and it is important that all patients receive high levels of care. If this does not happen, there are inevitable medical difficulties that put pressure on patients but put pressure on an already stretched NHS. own. "
Simon de Lusignan, professor of primary care and clinical informatics at the University of Surrey and Oxford University, said: "It's a concern that an imbalance is so recognized. Cost and accessibility may be limiting factors for screening and there are It is important that GPs emphasize to patients how monitoring is crucial to their long-term health. "
This study was undertaken as part of a research partnership between the University of Surrey and Eli Lilly and Company Limited.
Differences in glycemic control, monitoring and treatment of type 2 diabetes in England: retrospective cohort analysis. PLOS Medicine. Published: October 7 2019. https://doi.org/10.1371/journal.pmed.1002942
diabetes mellitus (t) United Kingdom Health Service (t) National Health Service (t) United Kingdom (t) NHS (t) National Health Service (t) United Kingdom Site Content (t) United Kingdom ( t (D) diabetes mellitus type 2 (t) diabetes mellitus type ii (t) type 2 diabetes (t) hemoglobin A1c (t) hemoglobin A1c test (t) hemoglobin clicked (t) glicosylated hemoglobin (t) HbA1c (t) A1C (t) Hb1c (t) glycohemoglobin (t) GHb (t) diabetic control index (t) A1C assessment (t) S